1. Health
You can opt-out at any time. Please refer to our privacy policy for contact information.

Antidepressants Grow New Brain Cells

By

Updated July 21, 2006

Antidepressants Grow New Brain Cells

Neurons under the microscope.

Research funded by the National Institute of Mental Health strongly suggests that some antidepressants work by growing new neurons (brain cells). One 2003 study, for example, found that blocking the formation of neurons in the hippocampus blocked the behavioral effects of the antidepressant fluoxitine (marketed as Prozac and Sarafem) in mice.

Studies had already demonstrated that depression and anxiety can cause loss of neurons. Other studies have shown that antidepressantscan triggerneuron growth, termed neurogenesis, in the hippocampus; but the significance of this was unclear. Here's how an NIMH press release summarized the research:

The researchers first showed that mice become less anxious – they begin eating sooner in a novel environment – after four weeks of antidepressant treatment, but not after just 5 days of such treatment. Paralleling the delay in onset of antidepressant efficacy in humans, the chronically-treated mice, but not the briefly-treated ones, showed a 60 percent boost in a telltale marker of neurogenesis in a key area of the hippocampus.

To find out if the observed neurogenesis is involved in antidepressants’ mechanism-of-action, Rene Hen, Ph.D and colleagues selectively targeted the hippocampus with x-rays to kill proliferating cells. This reduced neurogenesis by 85 percent. Antidepressants had no effect on anxiety and depression-related behaviors in the irradiated mice. For example, fluoxetine failed to improve grooming behavior, as it normally does, in animals whose behavior had deteriorated following chronic unpredictable stress. Evidence suggested that this could not be attributed to other effects of x-rays.

Neurons communicate with each other by secreting messenger chemicals, or neurotransmitters, such as serotonin, which cross the synaptic gulf between cells and bind to receptors on neighboring cell membranes. Medications that enhance such binding of serotonin to its receptors (serotonin selective reuptake inhibitors, or SSRIs) are widely prescribed to treat anxiety and depression, suggesting that these receptors play an important role in regulating emotions.

By knocking out the gene that codes for a key subtype of serotonin receptor (5-HT1A), the researchers created a strain of "knockout"micethat as adults show anxiety-related traits, such as a reluctance to begin eating in a novel environment. While unaffected by chronic treatment with the SSRI fluoxetine, the knockout mice became less anxious after chronic treatment with tricyclic antidepressants, which act via another neurotransmitter, norepinephrine, suggesting an independent molecular pathway.

While chronic fluoxetine treatment doubled the number of new hippocampal neurons in normal mice, it had no effect in the knockout mice. The tricyclic imipramine boosted neurogenesis in both types of mice, indicating that the serotonin 1A receptor is required for neurogenesis induced by fluoxetine, but not imipramine. Chronic treatment with a serotonin 1A-selective drug confirmed that activating the serotonin 1A receptor is sufficient to spur cell proliferation.

Keep reading for a discussion of what this really means...

©2014 About.com. All rights reserved.

We comply with the HONcode standard
for trustworthy health
information: verify here.